Exploitation of a non-apoptotic caspase to regulate the abundance of the cdkI p27KIP1 in transformed lymphoid cells
Open Access
- 17 May 2001
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 20 (22) , 2737-2748
- https://doi.org/10.1038/sj.onc.1204367
Abstract
Expression of the cyclin dependent kinase inhibitor p27KIP1 is intimately linked to the control of proliferation, and is itself regulated by transcription, translation, phosphorylation, protein stability or sequestration. p27KIP1 is also regulated during apoptosis; cleavage occurs at DPSD139S and ESQD108V, by a sub-set of Z-VAD-fmk-sensitive caspases. We have identified a related but distinct mechanism that regulates p27KIP1 in proliferating lymphoid cell lines. In a B-lymphoid cell line (BJAB), the abundance of p27KIP1 oscillates inversely to proliferation; loss of full-length p27KIP1 correlates with the appearance of a truncated version corresponding to cleavage at DPSD139S. A direct correlation exists between the appearance of truncated p27KIP1 and the presence of an activity able to cleave peptides representing DPSD139S and a caspase-8 substrate (Ac-IETD-AMC) in vitro. This activity is inhibited by Ac-IETD-CHO but not Z-VAD-fmk in vitro. Furthermore a requirement for caspase-8 has been excluded. The activity differs from the apoptosis related p27KIP1-cleaving activity; indeed few cells undergoing apoptosis are present in the population of proliferating cells. The activity is further distinguished by its inability to cleave a peptide based on ESQD108V in vitro, together with the lack of a corresponding cleavage product in vivo. Inhibition of the caspase activity in vivo promotes an accumulation of full length p27KIP1, as well as a decrease in cell proliferation. Together these studies highlight the importance of non-apoptotic caspases in regulating p27KIP1 in transformed lymphoid cells.Keywords
This publication has 58 references indexed in Scilit:
- p27KIP1 is down-regulated by two different mechanisms in human lymphoid cells undergoing apoptosisOncogene, 2000
- Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cellsOncogene, 1999
- Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27Kip1 mediates its anti-apoptotic activityOncogene, 1999
- Evidence for a p23 caspase-cleaved form of p27[KIP1] involved in G1 growth arrestOncogene, 1999
- p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cellsOncogene, 1999
- Inhibition of Human Caspases by Peptide-based and Macromolecular InhibitorsJournal of Biological Chemistry, 1998
- Cell Cycle-Dependent Phosphorylation of p27 Cyclin-Dependent Kinase (Cdk) Inhibitor by Cyclin E/Cdk2Biochemical and Biophysical Research Communications, 1997
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Genes & Development, 1994
- Production by EBV infection of an EBNA‐positive subline from an EBNA‐negative human lymphoma cell line without detectable EBV DNAInternational Journal of Cancer, 1975